HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Council’s Science Chief Bailey Reflects On Career “Being True To The Science”

This article was originally published in The Rose Sheet

Executive Summary

On May 31, the Personal Care Products Council announced the retirement of a key player in its work promoting the safe use of cosmetics, Chief Scientist John Bailey, who leaves the trade group July 29.

You may also be interested in...



PCPC Science Chief Approaches Public Safety Perceptions With “Real People” Experience

In an exclusive interview with “The Rose Sheet,” PCPC’s new Chief Scientist Beth Lange cites familiar challenges, including the need to combat misinformation regarding cosmetic ingredient safety. Formerly chief scientific officer at Mary Kay, Lange hopes to draw from her experience educating beauty consultants when engaging NGOs and addressing consumer concerns.

“Science Matters”: Council’s Breslawec Upholds Role Of Science In Cosmetics Safety Debate

“The Rose Sheet” interviews Halyna Breslawec, the Personal Care Products Council’s new chief scientist. Breslawec emphasized the role science plays for the industry.

“Extremist” Groups Needlessly Alarm Consumers About Cosmetics – Report

A new report from the Competitive Enterprise Institute suggests activist groups the Campaign for Safe Cosmetics and the Environmental Working Group are unnecessarily scaring consumers and influencing regulations to advance their own “anti-chemical” agendas.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017596

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel